Sanofi
Pegfilgrastim greenlight marks eighth biosimilar approval in Europe for Sandoz
November 27, 2018Manufacturing and Production, Sales and Marketing Amgen, Neulasta, Sanofi, Ziextenzo, biosimilars, pegfilgrastim, pharma
The European Commission has chosen to grant marketing authorisation to Ziextenzo, Sandoz’s biosimilar version of pegfilgrastim, better known as Amgen’s …
GSK retain top spot on access to medicines list
November 22, 2018Business Services, Research and Development GSK, J&J, JJ, R&D, Sanofi, access, low and middle income countries, researh
The majority (63%) of research and development projects are being conducted by just five companies; GSK, Johnson & Johnson, Sanofi, …
First-ever all-oral drug for sleeping sickness recommended for approval by EMA committee
November 20, 2018Manufacturing and Production, Sales and Marketing CHMP, EMA, Europe, Sanofi, fexinidazole, pharma, sleeping sickness
Sanofi’s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a …
Top Ten most popular articles on Pharmafile.com this week!
November 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10
Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …
Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal
November 1, 2018Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma
Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …
NICE turns down Sanofi’s Caprelsa for rare thyroid cancer
October 31, 2018Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma
NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …
MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes
October 15, 2018Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma
MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …
Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients
September 17, 2018Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …
Sanofi to pay $25m over Kazakhstan and Middle East corruption allegations
September 5, 2018Research and Development Kazakhstan, SEC, Sanofi, allegations, corruption, middle east
French pharma giant Sanofi will pay more than $25 million to settle corruption charges related to their subsidiaries in Kazakhstan …
UK research charity LifeArc appoints experienced leader Melanie Lee as new CEO
September 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, melanie lee
The life sciences medical research charity LifeArc, formerly MRC Technology, has appointed Dr Melanie Lee as its new Chief Executive …
European Commission authorises first-ever rare blood condition drug
September 4, 2018Manufacturing and Production, Sales and Marketing Europe, Sanofi, approvals, cablivi, eu commission
Sanofi have announced that the European Commission granted marketing authorisation for Cablivi (caplacizumab) for the treatment of adults experiencing an …
Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros
August 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda
The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Pfizer to consider stockpiling medicines in preperation for no-deal Brexit
August 6, 2018Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling
Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …
Top Ten most popular articles on Pharmafile.com this week
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10
While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
Two injured in chemical incident at Sanofi lab in Ireland
August 2, 2018Manufacturing and Production Ireland, Sanofi, pharma
Two female employees have been injured in a chemical incident at a Sanofi lab at the company’s Waterford site in …
